New radiation approach shows promise for prostate cancer control
NCT ID NCT02761889
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new way to give radiation therapy for prostate cancer. It used very precise, high-dose radiation over just five days. The goal was to control the cancer while reducing side effects on the bladder and bowel. 444 men with localized prostate cancer took part, and researchers tracked their health and quality of life for five years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PROSTATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Champalimaud Foundation
Lisbon, 1400-038, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Targeted radiation plus hormone therapy may slow Low-Volume prostate cancer spread
- Could a depression drug fight prostate cancer?
- New blood test aims to spot prostate cancer cells earlier
- Glow-in-the-Dark antibody could help surgeons spot prostate cancer
- High-dose radiation aims to control tough prostate cancer
- Precision proton beams take aim at High-Risk prostate tumors